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Exposure to environmental tobacco smoke
(ETS) has been associated with cardiovascu-
lar disease and death (1–8). Potential patho-
physiologic pathways leading from ETS
exposure to cardiopulmonary disease are still
being explored (5,9), but there has been a
growing recognition of the importance of
the autonomic nervous system in cardiovas-
cular disease (10). Various measures of heart
rate variability (HRV) evaluate changes in
beat-to-beat interval durations using electro-
cardiography (ECG). These HRV measures,
therefore, are noninvasive means to quantify
the state of cardiac autonomic function.
Reduced cardiac autonomic function, as
measured by reduced HRV, has been associ-
ated with increased cardiac vulnerability
(10–12). Is it possible that the autonomic
nervous system plays a role in the patho-
physiologic pathway between ETS exposure
and cardiopulmonary disease? 
Although various measures of HRV pro-
vide speciﬁc, well-deﬁned, quantitative indi-
cators of cardiac autonomic function (10),
we know of no human studies that have
evaluated the relationship between HRV and
acute exposure to ETS. Studies have shown
increases in HRV shortly after smoking ces-
sation (13,14) and changes in heart rate
(HR) (15) and HRV (16–18) associated
with acute exposure to respirable suspended
particles (RSP), primarily of outdoor origin.
Epidemiologic studies have also shown asso-
ciations between exposure to RSP and car-
diopulmonary disease similar to those
observed with ETS (19–23).
The objective of this study was to evalu-
ate potential effects of short-term ETS expo-
sure on changes in cardiac autonomic
function. Specifically, this study evaluated
effects of short-term exposure to ETS in a
commercial airport on cardiac autonomic
function as measured by HR and HRV in a
panel of adult nonsmokers. Associations
with blood oxygen saturation and ETS were
also evaluated.
Methods
Subject selection and study location. Sixteen
research subjects were recruited using the fol-
lowing inclusion criteria: a) was 21 years of
age or older; b) lived near Salt Lake City,
Utah; and c) was willing to participate.
Exclusion criteria included a) current smoker;
b) cardiac transplant, cardiac pacemaker, or
implantable deﬁbrillator; c) health problems
that exclude participation such as cold, flu,
other infectious illness, Parkinsonism, chronic
alcohol abuse, mental illness, or receiving oxy-
gen therapy. Recruitment goals included
having a wide range of adult ages and approx-
imately equal numbers of males and females.
Research protocols and consent forms were
approved by the institutional review board
for human subjects at Brigham Young
University. Before entering the study, all par-
ticipants read and signed consent forms, then
completed a questionnaire pertaining to
background information, medical history,
and prescription medications. Subjects
received $100 for participating in the study.
We obtained permission from manage-
ment and security personnel to conduct this
study at the Salt Lake City International
Airport where smoking is allowed only in
designated smoking areas. The study was
conducted in the airport’s C-concourse non-
smoking and smoking areas. The smoking
area was enclosed, but it had see-through
glass walls, nearly identical seating and light-
ing, and similar outside views of the tarmac
in the foreground and the Wasatch moun-
tains in the background.
Procedures at airport. Participants were
divided into two eight-person panels. Primary
data collection occurred on 22 December
1999 for the ﬁrst panel and 4 January 2000
for the second panel. We arranged for partici-
pants to travel to the airport and clear secu-
rity. We conducted continuous ambulatory
ECG monitoring for 8 hr while participants
alternated 2-hr periods in nonsmoking and
smoking areas, beginning in the nonsmoking
area. In both areas participants engaged in the
same types of activities including mostly sit-
ting while reading, visiting, playing cards, etc.
Food and drinks were provided during each
2-hr time period, and participants were asked
to eat similar amounts each time. During the
middle of each 2-hr period, research person-
nel took food orders, purchased food from
available airport vendors, and delivered it to
the participants.
Participants completed activity diaries,
including times when they moved from one
area to another, ate, went to the restroom, or
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Environmental tobacco smoke (ETS) has been associated with cardiovascular mortality.
Pathophysiologic pathways leading from ETS exposure to cardiopulmonary disease are still being
explored. Reduced cardiac autonomic function, as measured by heart rate variability (HRV), has
been associated with cardiac vulnerability and may represent an important pathophysiologic
mechanism linking ETS and risk of cardiac mortality. In this study we evaluated acute ETS expo-
sure in a commercial airport with changes in HRV in 16 adult nonsmokers. We conducted ambu-
latory electrocardiographic (ECG) monitoring for 8-hr periods while participants alternated 2 hr
in nonsmoking and smoking areas. Nicotine and respirable suspended particle concentrations and
participants’ blood oxygen saturation were also monitored. We calculated time and frequency
domain measures of HRV for periods in and out of the smoking area, and we evaluated associa-
tions with ETS using comparative statistics and regression modeling. ETS exposure was nega-
tively associated with all measures of HRV. During exposure periods, we observed an average
decrement of approximately 12% in the standard deviation of all normal-to-normal heart beat
intervals (an estimate of overall HRV). ETS exposures were not associated with mean heart rate
or blood oxygen saturation. Altered cardiac autonomic function, assessed by decrements in HRV,
is associated with acute exposure to ETS and may be part of the pathophysiologic mechanisms
linking ETS exposure and increased cardiac vulnerability. Key words: autonomic function, cardio-
vascular disease, environmental tobacco smoke, heart rate variability, particulate matter, passive
cigarette smoke. Environ Health Perspect 109:711–716 (2001). [Online 5 July 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/f/abstract.htmlhad any other signiﬁcant change in activity.
We created an activity index using informa-
tion recorded in the diaries. It was simply the
number of times that the individual ate or
did something that required standing up and
moving around, such as going to the
restroom or getting up for a drink, in each
1.75-hr period. During the last 15 min of
each 2-hr period the participants’ blood oxy-
gen saturation level (SpO2) was measured
using a Nellcor N-20P portable pulse oxime-
ter (Nellcor Inc., Hayward, CA). Participants
could withdraw at any time if they became ill
or uncomfortable, but all completed the
study.
Air quality monitoring and exposure
assessment. We conducted 2-hr integrated
sampling alternately in the smoking and
nonsmoking areas using samplers originally
designed to monitor ETS on commercial air-
craft. These samplers were self-contained in
large briefcases and have been described
elsewhere (24). Nicotine (25) and RSP (with
a cut point of 3 µm at the ﬂow used in this
study) were monitored at about the breath-
ing zone while the participant was sitting.
We used four ETS exposure variables in the
analysis: a) a smoking area indicator variable;
b) average number of lit cigarettes as counted
every 5 min; c) nicotine concentrations; and
d) RSP concentrations. We analyzed col-
lected RSP for sulfate and determined con-
centrations of carbon monoxide, carbon
dioxide, and nitrogen dioxide (24).
Ambulatory ECG monitoring and pro-
cessing. At the airport, participants went to a
private room and were hooked up to ambu-
latory ECG monitors by a trained techni-
cian. The hookup of a modiﬁed V5 and aVF
bipolar lead placement was used. Skin prepa-
ration, electrode placement, and related pro-
tocols were similar to those described
elsewhere (26). Electrocardiograms were
recorded digitally (sampling rate of 256 Hz
per channel) on removable ﬂash cards using
a light-weight, two-channel, ambulatory
ECG monitor (Trillium3000, Forest
Medical, East Syracuse, NY). The signal was
recorded continuously throughout the study
period. The ECG digital recordings were
processed, and HR and HRV measures were
calculated using PC-based software
(Trillium3000 PC Companion Software for
MS Windows, Forest Medical). Initially,
beats were automatically detected and
assigned tentative annotations, which were
then thoroughly reviewed by an experienced
scanner to correct for any mislabeled beats or
artifacts. Only normal-to-normal beat (NN)
intervals were included in the analysis.
The ECG recordings were divided into
time periods in and out of the smoking area.
For each 2-hr period, we deleted the ﬁrst 10
min and the last 5 min in order to minimize
the impact of disruptions and exposure mis-
classiﬁcation associated with the transitional
periods when participants moved to and
from the nonsmoking and smoking areas.
For each of the 1.75-hr time periods, we
then calculated mean HR, ﬁve time-domain
HRV measures, and five frequency domain
HRV measures, as described in Table 1.
In practice, time-domain and frequency-
domain measures are simply alternative
approaches to measuring HRV. The time-
domain calculations are easier to perform.
Because of both mathematical and physio-
logic relationships, there is approximate cor-
respondence between many of the time- and
frequency-domain variables and they are,
therefore, strongly correlated (10). For
example, the time-domain measures
Triangular Index and standard deviation of
all NN intervals (SDNN) and the fre-
quency-domain measure of total power are
Articles • Pope et al.
712 VOLUME 109 | NUMBER 7 | July 2001 • Environmental Health Perspectives
Table 1. Time and frequency domain measures of HRV used in analysis.
Variable Units Description
Time domain measures
Triangular Index The total number of all NN intervals divided by the NN histogram
height, an estimate of overall HRV.
SDNN msec The standard deviation of all NN intervals, an estimate of overall
variability.
SDANN msec The standard deviation of all 5-min NN interval means, an estimate
of long-term components of HRV.
SDNN Index msec The mean of all 5-min NN interval standard deviations, an estimate
of variability due to cycles shorter than ﬁve minutes.
r-MSSD msec The square root of the mean of the squared differences between 
adjacent NN intervals, an estimate of the short-term components
of variability.
Frequency domain measures
Total msec2 Total power, frequency range < 0.4 Hz.
ULF msec2 Power in the ultralow frequency range (< 0.003 Hz).
VLF msec2 Power in the very low frequency range (0.003–0.04 Hz). 
LF msec2 Power in the low frequency range (0.04–0.15 Hz).
HF msec2 Power in the high frequency range (0.15–0.4 Hz).
Table 2. Brief description of research subjects.
Subject Age/race/sex Smoking status Medical summary Prescription medication
1 37/black/M Quit 3 years ago Healthy None
2 22/white/M Never smoked Healthy None
3 66/white/M Never smoked Hypertension Cimetidine, lisinopril, loratadine, cetirizine
4 22/white/M Never smoked Healthy None
5 21/white/F Never smoked Healthy Loratadine/pseudoephedrine, ibuprofen
6 21/white/F Never smoked Healthy None
7 59/white/M Never smoked Asthma, borderline hypertension, diabetes Pseudoephedrine/quaifenesin, inhaled ﬂuticasone, albuterol, 
salmeterol, azelastine nasal spray, metformin, montelukast
8 46/white/F Never smoked Healthy Estrogen 
9 76/white/M Never smoked History of bronchitis, congenital renal disease,  Cyclosporin-A, azathioprine, prednisone, levothyroxine, 
renal transplant in 1994, abnormal heart  ranitidine
rhythm (premature depolarizations), 
hypothyroidism and diabetes
10 68/white/F Never smoked Shortness of breath walking uphill, history of  None
abnormal heart rhythm, poor circulation in feet
11 35/white/F Never smoked Healthy None
12 27/white/M Quit 4 years ago Healthy None
13 30/white/F Never smoked Healthy Oral contraceptive: levnorgestrel/ethinyl estradiol
14 60/white/M Never smoked Healthy None
15 62/white/F Never smoked Healthy None
16 68/white/M Never smoked Myocardial infarction, angioplasty, shortness  Isosorbide, furosemide, warfarin, potassium chloride, 
of breath, angina, and congestive heart failure nitroglycerine, losartan, carvedol, hydrocodone/acetaminophenall measures of overall HRV and, therefore,
are highly correlated. The time-domain mea-
sure r-MSSD (the square root of the mean of
the squared differences between adjacent
NN intervals) and the frequency-domain
measure HF are both measures of the very
short-term components of HRV and, there-
fore, are highly correlated.
We calculated frequency-domain mea-
surements using power spectral analysis
(10,27) following several approaches. First, a
basic long-term analysis was conducted using
a standard discrete Fourier transform algo-
rithm, as described in detail elsewhere (28).
We used all NN intervals in the 1.75-hr
periods to determine the five frequency-
domain measures described in Table 1.
Next, each of these five components were
reestimated after applying the Hamming
window (28). Finally, we conputed total,
very low frequency (VLF), low frequency
(LF), and high frequency (HF) for each 5-
min interval, also applying the Hamming
window. All of the 5-min interval values
were then averaged across the 1.75-hr peri-
ods. Correlations between the basic long-
term frequency domain estimates and those
applying the Hamming window for total,
ultralow frequency (ULF), VLF, LF, and HF
were high at 0.96, 0.88, 0.98, 0.98, and
0.98, respectively. Correlations between
measures of VLF, LF, and HF using the
basic long-term frequency domain estimates
versus averages of 5-min intervals were also
high at 0.98, 0.99, and 0.98, respectively.
Because the estimates from these three
approaches were so closely correlated, the
statistical analysis of HRV and ETS exposure
focused on the time-domain and basic long-
term frequency domain HRV measures.
Statistical analysis. Initially, we con-
ducted simple comparative statistics includ-
ing estimating relevant cross-correlation
coefficients and plotting measures of HRV
against exposure variables. Associations with
ETS were evaluated statistically using pooled
data and fixed-effects regression modeling
techniques (29). The basic regression models
for the HRV measures included one of the
ETS exposure variables, 16 subject-specific
indicator variables, and a time-period variable
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Table 3. Mean values of variables used in primary
analysis during periods in and out of the smoking
area.
Mean values
Nonsmoking Smoking 
Variable area area
description (n = 32) (n = 32) 
Exposure variables
No. of cigarettes 0.0 8.77
Nicotine (µg/m3) 0.43 34.03
RSP (µg/m3) 24.74 77.97
CO (ppm) 0.85 1.32
Activity index 1.94 1.63
Time domain HR, HRV
Mean HR (bpm) 77.63 79.39
Triangular Index 21.02 17.14
SDNN (msec) 80.41 68.91
SDANN (msec) 46.78 36.41
SDNN Index (msec) 57.31 52.03
r-MSSD (msec) 47.88 44.56
Frequency domain HRV
Total (msec2) 3,510 2,474
ULF (msec2) 1,567 954
VLF (msec2) 932 734
LF (msec2) 565 446
HF (msec2) 446 341
LF/HF 2.45 2.44
Oxygen saturation
SpO2 (%) 96.68 96.34
Figure 1. SDNN for subjects 1–8 and the mean SDNN across these subjects plotted over the 8 hr of the
study period and ETS exposures (22 December 1999, 1015–1815 hr). Nicotine and RSP concentrations,
respectively, were 0 µg/m3 and 43 µg/m3 for nonsmoking area1, 23 µg/m3 and 166 µg/m3 for smoking area1,
2 µg/m3 and 26 µg/m3 for nonsmoking area2, and 38 µg/m3 and 57 µg/m3 for smoking area2.
Table 4. Pearson correlation coefﬁcients between various HR and HRV variables (n = 64).
Mean HR Triangular Index SDNN SDANN SDNN Index r-MSSD
Triangular Index –0.48 1.00 0.86 0.76 0.86 0.29
SDNN –0.71 0.86 1.00 0.82 0.93 0.66
SDANN –0.57 0.76 0.82 1.00 0.62 0.31
SDNN Index –0.63 0.86 0.93 0.62 1.00 0.63
r-MSSD –0.58 0.29 0.66 0.31 0.63 1.00
Total –0.64 0.82 0.94 0.80 0.85 0.60
ULF –0.55 0.78 0.83 0.96 0.64 0.31
VLF –0.55 0.91 0.81 0.63 0.87 0.25
LF –0.51 0.72 0.82 0.51 0.82 0.62
HF –0.46 0.30 0.60 0.34 0.52 0.79
All correlation coefﬁcients > 0.35 were statistically signiﬁcant at p < 0.01. 
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Subject 8, 46 year F(1–4 corresponding to the four 2-hr exposure
periods) that allows for trending throughout
the 8-hr study period. Further analysis
included the estimation of models with other
variables such as the activity index and previ-
ous period RSP exposure. We estimated
autoregressive models that allowed for ﬁrst-
order nonindependent error terms using a
maximum likelihood method (30). Models
stratiﬁed for each of the 16 participants and
speciﬁc subgroups were also estimated.
Results
Table 2 provides a description of the
research subjects including nine men and
seven women ranging from 21 to 76 years of
age. Most were relatively healthy, but some
had a history of respiratory and/or cardiovas-
cular disease. All of the subjects were non-
smokers. Two had quit smoking 3 or 4 years
prior to the study. Comparisons of mean
values of key variables are presented in Table
3. Nicotine and RSP levels were substantially
higher in the smoking area. Average physical
activity levels were slightly lower during
smoking area periods, but mean HR was
1.76 beats/min higher. Measures of HRV
were consistently lower during periods in the
smoking area. Table 4 presents cross-correla-
tion coefﬁcients between the HR and HRV
variables. Mean HR was negatively corre-
lated with all measures of HRV. SDNN was
most highly correlated with measures of
overall HRV and estimates of the longer-
term components of variability, but SDNN
was also highly correlated with estimates of
short-term components of variability such as
r-MSSD (r = 0.66) and HF (r = 0.60).
Figures 1 and 2 present subject-specific
SDNN measures plotted over the study
period. Exposure periods, average number of
cigarettes smoked, and nicotine and RSP con-
centrations are also indicated. Data collection
for the ﬁrst panel occurred when the airport
was relatively more crowded due to elevated
preholiday traffic. RSP concentrations (but
not nicotine or number of smokers) were
higher for the ﬁrst panel—both in and out of
the smoking area. Most of the variability in
HRV was due to differences across individu-
als. For the majority of the subjects, SDNN
tended to decline after they moved into the
smoking area, recover when they returned to
the nonsmoking area, and then decline again
when they moved back to the smoking area.
A subtle decline in SDNN through the study
period may be part of a diurnal pattern or be
suggestive that the subjects do not fully
recover after the ﬁrst ETS exposure.
Table 5 shows the estimated regression
coefﬁcients between HR and HRV measures
and ETS exposure variables. The regression
models also included 16 subject-speciﬁc indi-
cator (ﬁxed-effects) variables and a time-trend
variable. For the HRV models, mean heart
rate was also included as a covariate. Mean
HR was not significantly associated with
ETS. All of the HRV measures were consis-
tently negatively associated with all four ETS
exposure variables. Associations with mea-
sures of overall HRV and measures of long-
term components of variability were more
strongly associated with ETS than were esti-
mates of the short-term components of vari-
ability. The LF/HF ratios were not
significantly associated with ETS exposure,
nor was SpO2.
Table 6 shows estimated regression coefﬁ-
cients between SDNN and the ETS exposure
variables for models controlling for different
combinations of covariates. Estimated asso-
ciations between HRV and ETS exposure
were not sensitive to controlling for other
nonexposure variables (Models 1–5). The
autoregressive term was generally not statisti-
cally signiﬁcant and had little impact on the
ETS effect estimates (Model 6). Mean HR
was often signiﬁcantly associated with HRV.
The regression coefficient (standard error)
for the mean HR variable, based on Model 3
in Table 6 using RSP as the exposure vari-
able, was –0.87 (0.45, p = 0.06). The activity
index and lagged PM values were never sta-
tistically signiﬁcant (p > 0.15). 
Subject-specific regressions indicated
that the associations between SDNN and
ETS variables were consistently negative for
all but two of the subjects. These two sub-
jects included subject 3, a medicated hyper-
tensive male, and subject 9, a diabetic male
who had a renal transplant and was taking
the immunosuppressant cyclosporin-A.
Regression models were estimated follow-
ing stratification by subject and specific
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Figure 2. SDNN for subjects 9–16 and the mean SDNN across these subjects plotted over the 8 hr of the
study period and ETS exposures. (4 January 2000, 0945–1745 hr). Nicotine and RSP concentrations,
respectively, were 0 µg/m3 and 18 µg/m3 for nonsmoking area1, 21 µg/m3 and 41 µg/m3 for smoking area1, 0
µg/m3 and 12 µg/m3 for nonsmoking area2, and 53 µg/m3 and 48 µg/m3 for smoking area2.
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Subject 16, 68 year Msubgroups. No clear differences were
observed across former smoking status and
age. The association between SDNN and
ETS exposure was greater for females than
for males, but the difference was greatly
attenuated excluding subjects 3 and 9.
Discussion
Although numerous epidemiologic investiga-
tions have shown associations between ETS
exposure and cardiovascular disease (1–8),
the pathophysiologic pathways need further
exploration. There has been growing recogni-
tion of the importance of the autonomic ner-
vous system in cardiovascular disease (10).
Deleterious health outcomes associated with
reduced cardiac autonomic function, as mea-
sured by time-domain and frequency-domain
measures of HRV, has been well established
(10–12,31). Parallel research has observed
associations between exposure to combus-
tion-related RSP from outdoor origin and
cardiopulmonary disease similar to associa-
tions observed with ETS (19–23). A few
recent studies have shown that acute changes
in exposure to RSP primarily from outdoor
origin are associated with short-term changes
in HR (15) and HRV (16–18). These ﬁnd-
ings have led to speculation that alterations in
cardiac autonomic control may represent an
important pathophysiologic mechanism by
which RSP lead to cardiac mortality (31).
Given that ETS is a primary source of
RSP exposure in many indoor environments,
in this study we explored effects of short-
term ETS exposure on changes in cardiac
autonomic function. We evaluated realistic,
real-world exposures to ETS by using smok-
ing areas in a commercial airport. Nicotine
and RSP concentrations observed during
exposure periods in this study were compara-
ble to concentrations common to many
workplace environments (32). In this study
we observed consistent decrements in HRV
associated with ETS exposure. Measures of
overall HRV and measures of long-term
components of variability were more strongly
associated with ETS than were estimates of
the short-term components of variability.
These results were quite robust, with similar
results being observed across various strata,
modeling approaches, and measures of HRV.
It is unclear which constituents of ETS
are responsible for the apparent effect on
HRV. It is unlikely that CO was primarily
responsible because the CO concentrations
were extremely low. The elevated nicotine
levels may play a role; however, in a recent
study of much higher nicotine exposure
through nicotine patch administration, only
minor changes in autonomic regulation were
found (33). The estimated HRV associations
with RSP observed in this study are some-
what comparable with those from recent air
pollution studies. A study of 26 elderly sub-
jects living in metropolitan Baltimore,
Maryland, (16) observed that 6-min SDNN,
LF, and HF were negatively associated with
ambient and indoor particulate pollution. In
a second air pollution study (17), weekly
ECG monitoring was conducted continu-
ously for 25 min in a controlled setting on
21 53–87 year-old subjects in Boston,
Massachusetts. Although RSP concentra-
tions never exceeded 50 µg/m3, based on the
reported regression coefﬁcients, a 100-µg/m3
increase in 4-hr RSP exposure was associated
with approximately a 25-msec decline in
both SDNN and r-MSSD.
Another air pollution study conducted
repeated 24-hr ambulatory ECG monitoring
on seven subjects in Utah during periods of
high and low ambient air pollution (18).
SDNN and SDANN (but not r-MSSD)
were signiﬁcantly negatively associated with
particulate air pollution. The estimated
decline in 24-hr SDNN associated with 100
µg/m3 in PM10 was approximately 18 msec
(SE = 4.9). In this ETS study, the estimated
decline in 1.75-hr SDNN associated with
100 µg/m3 in RSP was approximately 11
msec. Such comparisons of estimated effects
on HRV are not fully accurate because of
differences in exposure sources, exposure
measurements, and time frame of ECG
monitoring. Nevertheless, the estimated RSP
effects on HRV are somewhat consistent.
Also, consistent with the recent air pollution
studies, this study suggests that the effect of
exposure to ETS on HRV occurs rapidly and
is largely transient.
A recent prospective study of HRV and
mortality with chronic heart failure patients
was conducted by Nolan et al. (12). The rel-
ative risk associated with a 41.2-msec
decrease in SDNN (from 24-hr ambulatory
ECG monitoring) was 1.62 [95% confi-
dence interval (CI), 1.16–2.44]. By back-cal-
culating the proportional hazard regression
coefﬁcient from Nolan et al. (12) and using
our estimated reduction in SDNN from
ETS exposure from this study, an interesting
plausibility check can be made. The esti-
mated average decline in SDNN associated
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Table 5. Estimated regression coefﬁcients (standard errors) between HR and HRV measures and the ETS
exposure variables.
Regression coefﬁcients for exposure variables
Smoking area No. cigarettes Nicotine RSP
Variable indicator (×  10) (50 µg/m3) (100 µg/m3)
Mean HR (bpm) 0.66 (0.85) 0.25 (0.97) –0.23 (1.37) 0.38 (0.95)
Triangular Index –3.44 (0.84)# –3.46 (0.98)# –4.16 (1.44)# –3.50 (0.96)#
SDNN (msec) –9.61 (2.67)# –11.08 (2.97)# –13.71 (4.35)# –11.08 (2.92)#
SDANN (msec) –9.22 (3.46)** –10.86 (3.85)# –13.08 (5.58)** –10.90 (3.78)#
SDNN Index (msec) –4.40 (1.87)** –5.05 (2.10)** –6.34 (3.00)** –5.49 (2.04)#
r-MSSD (msec) –2.58 (3.23) –4.01 (3.61) –4.93 (5.11) –3.85 (3.56)
Total (msec2) –878 (250)# –1,043 (276)# –1,340 (400)# –1,000 (274)#
ULF (msec2) –526 (204)** –614 (227)# –725 (329)** –649 (221)#
VLF (msec2) –146 (57.9)** –149 (66)** –198 (94)** –163 (64)**
LF (msec2) –107 (47.1)** –132 (52)** –181 (74)** –110 (53)**
HF (msec2) –99.3 (76.7) –148 (85)* –235 (119)* –78 (86)
LF/HF –0.12 (0.19) –0.08 (0.21) –0.14 (0.30) –0.05 (0.21)
SpO2 (%) –0.08 (0.25) –0.01 (0.28) 0.19 (0.40) –0.23 (0.27)
Models also include 16 indicator (ﬁxed effects) variables for each individual, and a “time-trend” variable (1–4) indicated
the time period. Also for all the HRV models, mean heart rate is included as a variable in the models.
*, **, and # indicate p ≤ 0.10, 0.05, and 0.01, respectively; p-values are based on two-tailed t-tests and indicate the probabil-
ities for testing the null hypothesis that the parameter is not signiﬁcantly different from zero.
Table 6. Estimated regression coefﬁcients (SEs) between SDNN and the ETS exposure variables for models
that control for different covariates.
Regression coefﬁcients for exposure variables
Smoking area No. cigarettes Nicotine RSP
Other variables included in the model indicator (×  10) (50 µg/m3) (100 µg/m3)
Model 1. Subject indicator –11.50 –12.54 –14.02 –10.91 
(2.43)# (2.62)# (3.28)# (3.30)#
Model 2. Subject indicator, time period –10.13 –11.30 –13.48 –11.41
(2.71)# (3.07)# (4.52)# (3.00)#
Model 3. Subject indicator, time period,  –9.61 –11.08 –13.71 –11.08
mean HR (2.67)# (2.97)# (4.35)# (2.92)#
Model 4. Subject indicator, time period, –9.63  –11.20 –13.60  –11.35
mean HR, activity index (2.82)# (3.16)# (4.59)# (3.13)#
Model 5. Subject indicator, time period, –10.01  –11.58 –14.41  –10.60
mean HR, activity index, lagged RSP (3.57)# (3.93)# (6.29)** (3.42)#
Model 6. Subject indicator, time period, –9.59  –10.72  –12.95  –10.39
mean HR, autoregressive term (3.17)# (3.44)# (5.18)** (3.25)#
*, **, and # indicate p ≤ 0.10, 0.05, and 0.01, respectively; p-values are based on two-tailed t-tests and indicate the proba-
bilities for testing the null hypothesis that the parameter is not signiﬁcantly different from zero.with ETS exposure in the airport was approx-
imately 10 msec. Based on the results from
Nolan et al. (12), the estimated relative mor-
tality risk of a 10-msec decline in SDNN can
be calculated as 1.12 {e[10 × (ln1.62)/41.2]}. Lack
of compatibility between these studies, such
as SDNN calculations for different periods,
make comparing relative risk estimates
highly imprecise. Nevertheless, this esti-
mated risk ratio seems somewhat plausible
with an estimated excess risk about one-half
as large as the total ETS-related excess risk as
observed directly from epidemiologic stud-
ies. Meta-analyses of coronary events among
never-smokers who are married to smokers
compared to those married to nonsmokers
or exposed to ETS in the workplace yield
combined average relative risks of 1.25 (95%
CI, 1.17–1.33) (6) and 1.21 (95% CI,
1.04–1.41) (34), respectively. The total
ETS-related excess risks directly observed in
the epidemiologic studies are expected to be
larger because elevated exposure in this study
was only short term, whereas workplace- and
spousal-related exposures are long term.
Furthermore, altered cardiac autonomic con-
trol is likely only one of multiple mechanis-
tic links between ETS exposure and
cardiovascular disease mortality (9).
Mechanistic hypotheses by which res-
pirable particles affect neural control of the
heart have been proposed (31). Also, some
recent animal studies suggest that increased
cardiac vulnerability does not occur through
hypoxia, but through changes in cardiac
autonomic function (35). Mechanistic path-
ways by which ETS and other respirable par-
ticles may affect cardiac autonomic function
and risk of cardiovascular disease, however,
clearly need further exploration.
Although the associations between ETS
exposure and various measures of HRV
observed in this study were quite robust and
statistically signiﬁcant, the basic observations
of this study need to be replicated. This
study, nonetheless, suggests that altered car-
diac autonomic function, as reflected by
decrements in HRV, may be part of the
pathophysiologic mechanisms by which
exposure to ETS (and possibly other com-
bustion-related particulate pollutants) leads
to increased risk of cardiovascular mortality.
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